Small Molecule Drug Discovery Market Growth Trajectory – Insights On Key Drivers, Major Trends, And Top Opportunities

31 May, 2023

The global small molecule drug discovery market size is expected to grow from $52.14 billion in 2022 to $57.51 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global small molecule drug discovery market size is expected to reach $82.56 billion in 2027 at a CAGR of 9.5%.

Global Small Molecule Drug Discovery Market Key Driver

The increased prevalence of chronic diseases is predicted to drive future growth in the small molecule drug discovery market. Chronic diseases are ailments that persist a year or longer, interfere with daily activities, necessitate ongoing medical treatment, or both. Small-molecule drugs can be used to treat chronic illnesses such as HIV, cancer, infections, heart disease, and kidney disease, and they are generally less expensive for chronic-care patients. As a result, the growing prevalence of chronic diseases is likely to drive the small molecule drug discovery industry.

Get a sample of the global small molecule drug discovery market report

Global Small Molecule Drug Discovery Market Segments

The global small molecule drug discovery market is segmented:
1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process/Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others
6) By Geography: The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global small molecule drug discovery market.

Major Small Molecule Drug Discovery Industry Players

Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 21st Century Therapeutics Inc., 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Immunocure Inc., Labcorp Drug Development

Get the full global small molecule drug discovery market report

Small Molecule Drug Discovery Market Overview

Small molecule drug discovery refers to discovering a medicine with a low molecular weight that may easily penetrate cells. Small-molecule drugs are used to cure or prevent diseases.

Small Molecule Drug Discovery Global Market Report 2023 provides data on the global small molecule drug discovery market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The small molecule drug discovery market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.